Identification of A Novel Variant of Filamin A Destroying the Attraction Between Benzene Rings and Sulfhydryl in Developmental Dysplasia of the Hip.
Yi-Lei LuQin WangMin WangSi-Hua ChangJi-Qiang HeRong XiangJu-Yu TangJie-Yuan JinPublished in: DNA and cell biology (2023)
Developmental dysplasia of the hip (DDH), characterized by acetabular deformity that manifests from loose ligaments to complete dislocation of the hip, can cause notable pain and dysfunction and lead to hip dislocation, secondary fractures, scoliosis, and osteoarthritis of hip. Variants in FLNA may produce a spectrum of malformations in multiple organs, especially the skeleton. This study aimed to identify the genetic etiologies of DDH patients and provide genetic testing information for further diagnosis and treatment of DDH. We recruited a Chinese woman with DDH and her family members. Whole-exome sequencing was used to identify the patient's genetic etiologies. Protein models were used to analyze the pathogenic mechanism of the identified variants. A novel variant (c.3493T>G, p.C1165G) of FLNA was detected. The structural models of the mutant FLNA protein indicated that the variant would lose its sulfhydryl side chain and destroy the attraction between benzene rings and sulfhydryl. We reported a novel variant (c.3493T>G, p.C1165G) of FLNA in a Chinese woman with DDH. Our research outcome enriches the gene pool for hip dysplasia and emphasizes the pathogenicity of sulfhydryl side chain disruption in FLNA .
Keyphrases
- total hip arthroplasty
- copy number
- genome wide
- end stage renal disease
- case report
- oxidative stress
- chronic pain
- newly diagnosed
- chronic kidney disease
- ejection fraction
- healthcare
- escherichia coli
- spinal cord injury
- neuropathic pain
- dna methylation
- prognostic factors
- binding protein
- pain management
- knee osteoarthritis
- transcription factor
- wild type